Salvage treatment with hypofractionated radiotherapy in patients with recurrent small hepatocellular carcinoma

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 4, 2012, Pages

  Bae, Sun Hyun ^a   Park, Hee Chul ^a   Lim, Do Hoon ^a   Lee, Jung Ae ^a   Gwak, Geum Yeon ^a   Choi, Moon Seok ^a   Lee, Joon Hyoek ^a   Koh, Kwang Cheol ^a   Paik, Seung Woon ^a   Yoo, Byung Chul ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Hepatocellular carcinoma; Hypofractionation; Radiation therapy

Indexed keywords

COMPLETE RESPONSE; CRITICAL ORGANS; HEPATOCELLULAR CARCINOMA; HYPOFRACTIONATION; IN-FIELD; LIVER VOLUME; LOCAL CONTROL; OVERALL SURVIVAL RATES; PORTAL VEINS; SALVAGE TREATMENT; TUMOR RESPONSE;

LIVER; TOXICITY; TUMORS;

RADIOTHERAPY;

ADULT; AGED; ANOREXIA; ARTICLE; ASCITES; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHEMOEMBOLIZATION; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER METASTASIS; LIVER WEIGHT; MALE; NAUSEA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; RADIOFREQUENCY ABLATION; SALVAGE THERAPY; TREATMENT FAILURE; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; CARCINOMA, SMALL CELL; DOSE FRACTIONATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84857916723     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.053     Document Type: Article

References (23)

1. K. Okuda, T. Ohtsuki, and H. Obata Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients Cancer 56 1985 918 928
2. J. Bruix, M. Sherman, and J.M. Llovet Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver J Hepatol 35 2001 421 430
3. Primary liver cancer in Japan. Clinicopathologic features and results of surgical treatment. Liver Cancer Study Group of Japan Ann Surg 211 1990 277 287
4. N. Yamanaka, E. Okamoto, and A. Toyosaka Prognostic factors after hepatectomy for hepatocellular carcinomas. A univariate and multivariate analysis Cancer 65 1990 1104 1110
5. J. Bruix, and M. Sherman Management of hepatocellular carcinoma Hepatology 42 2005 1208 1236
6. T.S. Lawrence, J.M. Robertson, and M.S. Anscher Hepatic toxicity resulting from cancer treatment Int J Radiat Oncol Biol Phys 31 1995 1237 1248
7. [Practice guidelines for management of hepatocellular carcinoma 2009] Korean J Hepatol 15 2009 391 423
8. K.K. Herfarth, J. Debus, and F. Lohr Stereotactic single-dose radiation therapy of liver tumors: Results of a phase I/II trial J Clin Oncol 19 2001 164 170
9. L.A. Dawson, C. Eccles, and T. Craig Individualized image guided iso-NTCP based liver cancer SBRT Acta Oncol 45 2006 856 864
10. B.O. Choi, I.B. Choi, and H.S. Jang Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: Preliminary analysis BMC Cancer 8 2008 351
11. A. Takeda, M. Takahashi, and E. Kunieda Hypofractionated stereotactic radiotherapy with and without transarterial chemoembolization for small hepatocellular carcinoma not eligible for other ablation therapies: Preliminary results for efficacy and toxicity Hepatol Res 38 2008 60 69
12. R.V. Tse, M. Hawkins, and G. Lockwood Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma J Clin Oncol 26 2008 657 664
13. Y.S. Seo, M.S. Kim, and S.Y. Yoo Preliminary result of stereotactic body radiotherapy as a local salvage treatment for inoperable hepatocellular carcinoma J Surg Oncol 102 2010 209 214
14. A.B. Miller, B. Hoogstraten, and M. Staquet Reporting results of cancer treatment Cancer 47 1981 207 214
15. J. Seong, I.J. Lee, and S.J. Shim A multicenter retrospective cohort study of practice patterns and clinical outcome on radiotherapy for hepatocellular carcinoma in Korea Liver Int 29 2009 147 152
16. F. Mornex, N. Girard, and C. Beziat Feasibility and efficacy of high-dose three-dimensional-conformal radiotherapy in cirrhotic patients with small-size hepatocellular carcinoma non-eligible for curative therapies-mature results of the French Phase II RTF-1 trial Int J Radiat Oncol Biol Phys 66 2006 1152 1158
17. D. Oh, H. Lim do, and H.C. Park Early three-dimensional conformal radiotherapy for patients with unresectable hepatocellular carcinoma after incomplete transcatheter arterial chemoembolization: A prospective evaluation of efficacy and toxicity Am J Clin Oncol 33 2010 370 375
18. S. Krishnan, L.A. Dawson, and J. Seong Radiotherapy for hepatocellular carcinoma: An overview Ann Surg Oncol 15 2008 1015 1024
19. T. Livraghi, S. Lazzaroni, and F. Meloni Radiofrequency thermal ablation of hepatocellular carcinoma Eur J Ultrasound 13 2001 159 166
20. H. Kim, H. Rhim, and D. Choi Recurrence and treatment pattern in long-term survivors with hepatocellular carcinoma: A comparison between radiofrequency ablation and surgery as a first-line treatment World J Surg 34 2010 1881 1886
21. T.E. Schefter, B.D. Kavanagh, and R.D. Timmerman A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases Int J Radiat Oncol Biol Phys 62 2005 1371 1378
22. K.E. Rusthoven, B.D. Kavanagh, and H. Cardenes Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases J Clin Oncol 27 2009 1572 1578
23. C. Penna, and B. Nordlinger Colorectal metastasis (liver and lung) Surg Clin North Am 82 2002 1075 1090 x-xi